Jarrett Jennifer's Form 4 filing
Arcus Biosciences, Inc. (RCUS) · filed Jul 31, 2023
- Accession no.
- 0001209191-23-043821
- Filed
- Jul 31, 2023
- Trade date
- Jul 28, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $911.3K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jarrett JenniferCIK 0001671311 | Director, Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2023 | Common Stock | SSaleDisposed | −45,000 | $20.25 | −$911,250 | 336,566 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.